4.1 Article

Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US

Journal

JOURNAL OF MEDICAL ECONOMICS
Volume 15, Issue sup2, Pages 6-13

Publisher

Informa Healthcare
DOI: 10.3111/13696998.2012.708691

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available